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Resumo 
 
O número crescente de bactérias patogénicas resistentes aos antibióticos convencionais é 
atualmente uma das maiores preocupações, quer social como cientificamente. Com este 
cenário, a procura de alternativas terapêuticas tornou-se uma tarefa de enorme importância. 
Neste contexto, a investigação dedicada a péptidos antimicrobianos (AMP – antimicrobial 
peptides) tem aumentado, principalmente devido ao facto destas moléculas possuirem um 
grande espetro de ação contra uma variedade de agentes patogénicos (incluindo bactérias, 
vírus, fungos e parasitas). Mais especificamente, nos últimos anos, os esforços para sintetizar 
péptidos que possuam propriedades terapêuticas melhoradas em relação aos AMPs que se 
encontram na natureza têm aumentado. Com este objetivo em mente, estudos da relação entre 
atividade e propriedades físico-químicas dos AMP têm-se revelado de maior importância. 
Apesar de serem moléculas estruralmente muito variadas, algumas propriedades têm sido 
descritas como comuns, entre elas, a anfipaticidade e a carga global positiva. O principal 
mecanismo de ação até hoje descrito é a permeabilização seletiva das biomembranas dos 
organismos alvo, apresentando baixa ou nenhuma toxicidade para as células do organismo. 
Vários modelos têm sido propostos na tentativa de justificar o modo de ação dos AMPs na 
permeabilização de membranas, quer pela formação de poros que leva à destruição das 
membranas, quer mediante uma atividade de degradação direta, a qual se definiu como sendo 
"do tipo detergente". Quanto à seletividade membranar, as forças eletrostáticas têm uma 
grande contribuição. Enquanto as membranas de bactérias são ricas em lípidos aniónicos, o 
que promove a interação com os AMPs (altamente catiónicos), as membranas das células do 
hospedeiro possuem um folheto externo neutro (zwitteriónico), explicando-se assim a 
seletividade celular observada para vários AMPs. No entanto, vários estudos sugerem que 
componentes específicos das membranas bacterianas podem também desempenhar um papel 
importante na seletividade dos péptidos. 
O EcAMP1R2 é um péptido recentemente desenvolvido com base em modelos 
computacionais de desenho racional de AMPs, que toma em consideração as propriedades do 
mesmo e que poderão aumentar a actividade antimicrobiana. Especificamente, este AMP 
demonstrou uma elevada atividade antimicrobiana contra E. coli, uma bactéria Gram-
negativa, responsável por diversas patologias infecciosas. É relevante referir que este péptido 
não apresenta atividade contra células humanas. EcAMP1R2 tem uma carga global positiva 
(+5), numa sequência de 19 resíduos de aminoácidos. Em estudos preliminares observou-se 
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que adota preferencialmente uma estrutura secundária em α-hélice, aquando da presença de 
sistemas membranares hidrofóbicos, contrariamente ao apresentado em solução aquosa, onde 
não se observou uma estrutura definida (random coiled). Ao longo deste trabalho, estudaram-
se as propriedades de seletividade membranar, bem como os possíveis mecanismos de ação 
deste novo AMP, recorrendo-se a técnicas de espectroscopia de fluorescência e de dispersão 
de luz. Como sistemas modelo de membranas usaram-se lipossomas (LUVs; large 
unilamellar vesicles) e, para além destes, células de Escherichia coli, tendo em conta que a 
ação deste péptido tinha sido observada para membranas aniónicas de bactérias Gram-
negativas. Por um lado, a variação de intensidade de fluorescência intrínseca do péptido 
(possível devido à presença de um resíduo de triptofano no C-terminal) foi seguida para 
quantificar a inserção do péptido em membranas e testar a especificidade de ação do mesmo, 
tendo em conta o sistema membranar usado. A acrilamida, uma molécula capaz de extinguir a 
fluorescência de resíduos de triptofano, foi usada de forma a avaliar o grau de internalização 
deste. Sondas fluorescentes foram também testadas, quer em lipossomas, quer em células 
bacterianas, de forma a ser possível analisar as alterações nas diferentes propriedades 
membranares que o péptido provoca. Entre essas propriedades, a fluidez, o empacotamento 
lipídico e o potencial dipolar de membrana foram estudadas, usando para tal DPH / TMA-
DPH, Laurdano e di-8-ANEPPS como sondas repórter, respetivamente. Possíveis alterações 
no potencial superficial membranar de vesículas e de células bacterianas foram estudadas 
recorrendo-se a medidas de potencial-zeta. A dispersão dinâmica de luz permitiu estudar 
efeitos de agregação lipídica. Em todos os estudos realizados, a constituição lipídica das 
vesículas foi semelhante, tendo sido escolhido com base na ação do péptido. Vesículas de 
POPC foram estudadas como controlo negativo da ação do péptido. De forma a mimetizar a 
membrana bacteriana, lipossomas de POPC:POPG (70/30), POPE:POPG:CL (63/33/4) e 
POPE:POPG:CL:LPS (80/16/1/3) foram testadas, com as duas últimas constituições a 
mimetizar as membranas externa (OML) e interna (IML) de bactérias Gram-negativas, 
respetivamente. Vesículas lipídicas neutras enriquecidas em colesterol, POPC:Chol (70/30), 
foram também testadas, mimetizando células humanas saudáveis. Comparando os resultados 
obtidos para todas estas vesículas, foi-nos possível elucidar a contribuição relativa que os 
diferentes lípidos presentes nas membranas poderão ter nas interações péptido-membrana. 
Os resultados obtidos confirmaram a importância das forças eletroestáticas para a 
selectividade membranar do péptido EcAMP1R2, que se mostrou específico para membranas 
aniónicas, não tendo ação em membranas neutras. Esta especificidade pode ser deduzida 
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directamente a partir dos resultados de partição membranar e de extinção de fluorescência, 
mas também observando que não promove quaisquer alterações das propriedades das 
membranas estudadas. Deste modo, justifica-se o facto de não ter qualquer efeito tóxico em 
células humanas, cujas membranas são maioritariamente neutras. Por outro lado, os resultados 
sugerem que a afinidade do péptido por vesículas aniónicas é maior nas que mimetizam a 
membrana interna e externa de bactérias. Este resultado sugere que a presença de lípidos 
específicos, como a cardiolipina e o LPS, poderá ser determinante para a acção do AMP. A 
presença de LPS surge aqui como essencial para que as interacções iniciais ocorram e 
promovam a interação péptido-membrana, já que é tanto nas vesículas de OML como nas 
células de E. coli que o potencial dipolar sofre mais alterações (os únicos sistemas testados na 
presença destas moléculas). Poder-se-á dizer que a membrana externa surge assim 
inicialmente como o alvo preferencial para este AMP. 
Relativamente às outras propriedades membranares estudadas, a ação do EcAMP1R2 não 
levou a nenhuma alteração de fluidez, independentemente do sistema estudado, sendo apenas 
possível observar uma pequena alteração do empacotamento lipídico em vesículas que 
mimetizam a membrana interna bacteriana (IML), sugerindo assim que este AMP é também 
capaz, após internalização, de atuar na membrana interna das bactérias. Curiosamente, estas 
vesículas foram as únicas que agregaram após um aumento crescente da concentração de 
péptido, embora não tenha sido seguido duma neutralização das cargas superficiais. Com base 
nestes dados, foi possível formular a hipótese que este AMP promove processos de fusão ou 
hemifusão membranar, após internalização ou destruição da membrana externa de bactérias 
Gram-negativas. Uma das explicações que poderá corroborar esta hipótese é o facto de lípidos 
com curvatura intrínseca, como é o caso da cardiolipina, favorecerem este tipo de processos.  
Concluindo, os resultados obtidos ao longo deste estudo sugerem que o péptido 
antimicrobiano EcAMP1R2 poderá ser um bom candidato para o tratamento de infeções 
causadas por bactérias Gram-negativas. Demonstrou-se que os modelos de membrana simples 
são aproximações de constituições lipídicas controláveis que permitem extrapolar, com uma 
boa aproximação, o modo de ação de moléculas biologicamente relevantes.  
 
Palavras chave: Péptido antimicrobiano; EcAMP1R2; interação péptido-membrana; bactérias 
Gram-negativas. 
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Abstract 
Tackling antibiotic resistance is a worldwide priority. Antimicrobial peptides (AMPs) have been 
pointed as promising antimicrobial alternatives to conventional antibiotics. Most AMPs are 
cationic amphiphiles that kill bacteria by selectively attach and disrupt their negatively charged 
membranes. EcAMP1R2 is a newly designed cationic AMP with a high antimicrobial activity 
against Escherichia coli, without being cytotoxic to mammalian cells.  
Although the structure of EcAMP1R2 was well characterized in preliminary work, its activity is 
not well understood. In this work, we tried to elucidate the membrane selectivity and membrane 
activity of EcAMP1R2 in biomembrane models and Escherichia coli cells, by using optical 
spectroscopic techniques. Large unilamellar vesicles (LUVs) with different lipid compositions 
were used, including two mixtures mimicking the outer (OML) and the inner (IML) membranes 
of E. coli. Following the intrinsic fluorescence of the tryptophan residue of the peptide, it was 
observed that EcAMP1R2 discriminates between zwitterionic (mammalian-like) and anionic 
(bacterial-like) membranes. The effect of EcAMP1R2 on the physical properties of the 
membranes was monitored using diverse membrane probes. Finally, light scattering spectroscopy 
techniques were used to follow possible vesicle aggregation or changes in membrane surface 
charge due to the action of the peptide. Our results suggest that EcAMP1R2 internalizes deeply 
inside the outer membrane of E. coli, causing changes in the dipole potential, but little alterations 
on the surface charge. Moreover, EcAMP1R2 shows preferential affinity towards model 
membranes enriched in lipopolysaccharide, the major component of the outer membrane of 
Gram-negative bacteria. Additionaly, EcAMP1R2 promotes the aggregation of IML vesicles, 
with which also demonstrates high affinity, without neutralizing the surface charge. This has led 
us to hypothesize that an increased selectivity of EcAMP1R2 towards cardiolipin molecules of 
these vesicles leads to a hemi-fusion or fusion process.  
Key words: antimicrobial peptides, EcAMP1R2, peptide-membrane interactions, Gram-negative 
bacteria. 
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Introduction 
In the 1940s, the introduction of penicillin gave rise to the era of antibiotics, which was a 
breakthrough in modern medicine, allowing an effective fight against bacterial infections. 
However, the extensive misuse of antibiotics in livestock and in medicine has favored the 
emerging of antimicrobial resistance (AMR). As a result, an apocalyptic scenario in which 
minor infections may kill is no longer a fantasy1. Moreover, the thriving of antimicrobial 
resistant bacteria could eventually turn impossible the development of key medical procedures 
dependant on antibiotics (e.g. surgery, chemotherapy). Estimations suggest that in 2050, 
AMR will cause ten million deaths every year, outreaching the current mortality of cancer1,2. 
Unfortunately, the development of new antibiotic molecules is tremendously expensive and 
time consuming, and as a result, most of the pharmaceutical companies have left this area3.  
 
1. Antimicrobial peptides 
Antimicrobial peptides (AMPs) represent one of the most ancient forms of defense against 
infection. This idea is reinforced with the fact that there have been found AMPs in all 
domains of life (see antimicrobial peptide database [APD]4). In vertebrates, AMPs are 
included in the innate branch of the immune system. In humans, AMPs are mainly secreted by 
mucosal surfaces and by neutrophils5. In addition to their ability to kill potential pathogens, 
some AMPs have demonstrated immunomodulatory properties, thus being referred to as host 
defense peptides (HDPs)6–8. Likewise other components of the innate immune system, AMPs 
display a broad spectrum of antimicrobial activity, protecting against an extensive array of 
infective agents, some of them being even effective against cancer cells (anticancer peptides, 
ACPs)6,9,10. The selectivity of AMPs is dependent upon general biochemical traits that 
membranes of potential pathogens share. For instance, they are usually cationic, being thus 
prone to attach through electrostatic forces to the negatively charged membranes of bacteria. 
Membranes of mammalian cells, on the other hand, are neutrally charged, preventing AMPs 
from interacting with them through electrostatic forces.  
Regarding the mode of action, it is commonly accepted that AMPs act by permeabilizing 
membranes, following a general pattern. Briefly, peptide molecules adsorb to the bacterial 
membrane through electrostatic-driven interactions. Following this, folding of the peptide 
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occurs facilitating the insertion of the peptide, resulting in a disturbance of the membrane11. 
The question of how the peptide causes a membrane disruption enough to kill has been 
studied, and some models have been proposed. The most widely accepted models are the pore 
formation and the detergent-like models (Figure 1). Among the most frequently identified 
peptide-induced pore formation mechanisms are the toroidal and the barrel-stave pore models. 
In the barrel-stave model, peptides insert perpendicular relative to the plane of the bilayer, 
forming the "staves" in a "barrel-shaped" cluster. In the toroidal model, peptides also align 
perpendicular to the membrane, but in this case the interaction will cause an inwards bending 
of the membrane, so that the bilayer also lines the pore. However, although permeabilization 
seems to be crucial for the peptide action, it might be insufficient to explain antimicrobial 
activity. Besides, the accumulation of evidences that do not fit into these models have led to 
the formulation of new ones, some of which will be explored later12,13.  
 
 
Figure 1. Mechanisms of mode of action proposed for AMP. (A) Simplified representation of an α-helical AMP. 
Hydrophobic residues are highlighted in blue and the cationic ones in red. (B) Pore formation: peptides insert 
perpendicularly in the bilayer, associate and form a pore. (C) Detergent like activity (carpet model): peptides 
adsorb parallel to the membrane, and after a concentration threshold is reached, they disrupt the membrane 
through a detergent-like mechanism, causing micellization of the membranes. (Adapted from Computational 
Peptidology14) 
 
Certain AMPs kill microbes by targeting intracellular components, namely DNA and RNA15. 
In these cases, membrane permeabilization is not necessary for the antimicrobial activity. 
Still, interaction with membranes is a necessary condition, because the AMP must cross the 
cytoplasmatic membrane in order to reach its intracellular target.  
A B 
C 
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As to their clinical potential, AMPs display several desirable features. First, the already 
mentioned ability to kill rapidly a broad spectrum of infectious agents in the low micromolar 
range16,17. Moreover, it has been argued that bacteria will less likely develop resistance to 
AMPs, compared to conventional antibiotics18. The justification to this is that AMPs act on 
generalized targets such as membranes, while conventional antibiotics act upon specific 
targets such as bacterial enzymes. Thus, resistance to AMPs would involve such membrane 
rearrangements that would severely affect the bacterium fitness18,19. Still, as these peptides 
would exert selective pressures over bacteria, resistance will eventually appear, as it has been 
already reported20. However, recent studies suggest that AMPs do not elevate mutation rates 
as conventional antibiotics do. This confers an overwhelming advantage of AMPs over 
antibiotics, since mutation rate is closely related with speed of adaptation21.  
 
2. Molecular determinants of the membrane-AMP interaction. 
AMPs are generally short peptides (10 - 50 amino acid residues) with varied amino acid 
composition and structure. However, most described antibacterial AMPs are random coiled 
when embedded in the aqueous bulk and acquire an α-helical structure upon interaction with 
bacterial membrane12. This conformational flexibility is a key property of AMPs22. Besides, 
they are generally cationic-amphipathic molecules. The positive charge of the peptide 
determines the selective adsorption to the anionic membranes of bacteria. Amphipathicity (i.e. 
the relative proportion and distribution of hydrophobic and polar residues within the peptide) 
is crucial for the mechanism of action and the secondary structure of the peptide. While 
cationic amino acids are responsible for the initial interaction to the membrane, hydrophobic 
residues are crucial for the partition of the peptide into the non-polar core of the bacterial 
membrane23–25.  
On the other hand, some biochemical traits of bacterial membranes are key determinants of 
the nature of the interaction with the peptide. Bacterial membranes have usually variable 
proportions of negatively charged phospholipids, such as phosphatidylglycerol or cardiolipin, 
being usually higher in Gram-positive bacteria26. In addition, some AMPs display increased 
affinities towards specific membrane constituents, namely the head groups of certain 
phospholipids12,27,28. Usually, the higher fluidity of bacterial membranes comparatively to the 
membranes of animal cells (cholesterol-enriched) makes the first more prone to disruption by 
the action of AMPs29,30. Furthermore, bacteria usually display higher transmembrane potential 
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(more negative in the inside), which may act as a driving force for peptide insertion and 
translocation. How the peptide orientates in the bacterial membrane is particularly affected by 
its curvature strain, which in turn depends on the shape of the lipid constituents of the 
bilayer12,25,31. 
Finally, the nature of the cell wall is also definitive for the bacterial susceptibility to AMPs. 
The Gram-positive cell wall is made up by a main thick matrix of peptidoglycan enriched in 
anionic molecules such as teichoic and teichuronic acids (Figure 2). AMPs take advantage of 
these cell wall components to reach the plasmatic membrane, although the mechanism by 
which they do so is not yet fully understood12,20. Gram-negative bacteria, conversely, have a 
minor peptidoglycan matrix, but possess an outer membrane, with diverse lipoproteins 
maintaining it anchored to the peptidoglycan layer (Figure 2). Lipid components of the outer 
membrane are asymmetrically distributed. The inner leaflet of the Gram-negative outer 
membrane has a similar lipid composition to the cytoplasmic membrane, including anionic 
cardiolipin and phosphatidylglycerol32. On the other hand, the major component of the outer 
leaflet is the anionic lipopolysaccharide (LPS)33. Many peptides have shown to self promote 
their uptake by displacing the native cations (Mg2+ and Ca2+) of the LPS. Besides, being 
bulky, they disrupt the normal barrier of the outer membrane34.  
 
 
Figure 2. Scheme of the cell wall in Gram-positive and Gram-negative bacteria. The main differential 
components are discussed in the text (Free License)35. 
3. Design of synthetic AMPs 
In spite of the initial high hopes raised by naturally occurring AMPs, they did not meet some 
requirements necessary to be implemented as antimicrobial agents. The main limitations of 
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many naturally occurring AMPs are high manufacturing costs, undesirable toxicity against 
host cells, poor pharmacokinetic properties and low efficiency, being some susceptible to in 
vivo proteolysis16. Still, AMPs have multiple attributes that makes them very convenient as 
potential antimicrobial drugs36. Being relatively small molecules, AMPs can be easily 
manipulated and modified. There have been extensive efforts aiming to design synthetic 
improved (e.g. shorter sequences associated to lower production costs, more potent or less 
cytotoxic, resistant to proteolysis) variants of AMPs34,37. In order to fully exploit the 
therapeutic potential of these molecules it is fundamental to unravel the structural 
determinants that govern their biological activity. Traditional approaches involved sequence 
modification of natural templates, and have enabled extensive progresses in the understanding 
of structure-activity relationships (SARs) of AMPs38,39. Diverse approaches have been used, 
based on the activity comparison between peptide variants altered in some of their properties, 
such as size, charge, hydrophobicity or secondary structure12,40. As a result, now we 
understand that peptide alteration in some of the biochemical properties beyond a threshold 
can result in drastic alterations in toxicity, stability or activity12,19,41. 
However, the operational capacity of traditional SAR-based methods is low, costly and time-
consuming. In this sense, the thriving of bioinformatics has been greatly helpful. For instance, 
diverse AMP sequence databases have been created, such as the APD, that provide a great 
source of templates to work with and an indispensable knowledge base for activity prediction 
models39. Moreover, computational-biophysical approaches, are enhancing the predictive 
capacity that has allowed a radical improvement in the AMPs design39. Molecular modeling, 
for instance, is used to predict the three dimensional structure and the dynamics of a peptide14. 
Although with still some limitations, computational techniques are continually evolving, and 
facilitate the design procedure by allowing a sequence screening in AMP databases and the 
selection of a workable load of potential candidates for synthesis and experimental testing. 
 
 
4. EcAMP1R2: a novel synthetic cationic AMP  
This work is an exploration of the biological activity of a synthetic antimicrobial peptide 
named EcAMP1R2. This peptide was designed by the group headed by Prof. Octavio L. 
Franco, from Universidade Católica de Brasília and Universidade Católica Dom Bosco 
(Campo Grande, Brazil), with whom we have been collaborating in this project. The design of 
EcAMP1R2 was based on a predictive bioinformatic algorithm that took into account the 
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properties that lead to a higher antimicrobial activity, but whose characteristics are yet 
unpublished. Therefore, the exact sequence of the peptide will not be detailed for the sake of 
respect to the intellectual property. However, some of its structural characteristics will be 
exposed to give a perspective as broad as possible. EcAMP1R2 is an amphiphilic-cationic 
peptide with 19 amino acid residues and a net charge of +5. A relevant characteristic of 
EcAMP1R2 is that it has a C-terminal tryptophan residue. Tryptophan is an intrinsically 
fluorescent amino acid42, which makes it very convenient in the study of peptide-membrane 
interactions using fluorescence spectroscopy. Fluorescence spectroscopy techniques are 
among the most sensitive and suitable tools in the study of membrane active peptides43,44. 
Besides, being hydrophobic and bulky, tryptophan is also a suitable amino acid when it comes 
to designing antibacterial AMPs 23,45. 
4.1. Preliminary results 
The in vitro activity of EcAMP1R2 was assessed, showing a relatively high antimicrobial 
activity against the Gram-negative bacterium Escherichia coli (ATCC 25922). This bacterium 
belongs to the family Enterobacteriaceae, and is a species with a large sanitary interest. 
Although it is a normal inhabitant of the gut, some strains contain virulence factors that makes 
them hazardous. Recently, carbapenem-resistant Enterobacteriaceae (CRE) have been 
included by the CDC (Centers for Disease Control and Prevention, USA) in the maximum 
level of concern46,47. Carbapenem is a last resort β-lactam antibiotic that has been used for 
years to treat infections of resistant Enterobacteriaceae, including those producing extended 
spectrum β-lactamases46. Flow cytometry studies aiming to elucidate the permeabilization 
ability of EcAMP1R2 over time in E. coli (ATCC 25922) were carried out. The results 
showed the velocity of action of the peptide. Cytotoxicity assays for EcAMP1R2 were also 
carried out. The results neither show hemolytic activity against human erythrocytes nor 
cytotoxic effects against RAW 264.7 monocyte cell line, up to the maximum concentration 
(200 µg/mL) used in the bioassays (unpublished data).  
Using computational tools, diverse structural and functional aspects of EcAMP1R2 were 
predicted. The adoption of a secondary structure in the presence of solvents with different 
polarities, predicted by molecular dynamics simulations, show a secondary structure (α-helix) 
loss in polar solvents, maintaining the N-terminal structured (Figure 3.A). The results of these 
simulations is a trajectory recording the detailed dynamics of each atom of the different 
molecules involved14. 
 [7]  
 
 
 
Figure 3. Snapshots obtained by molecular dynamics simulations. (A) Prediction of the secondary structure of 
EcAMP1R2 along 100 ns, in water. (B) Prediction of the positioning (docking) of the peptide upon interaction 
with three membrane compositions: from left to right, POPC:cholesterol (70/30), pure POPC and POPC:POPG 
(70/30).  
Molecular docking can predict the preferred orientation of the peptide upon interacting with 
membranes with diverse lipid compositions14. Figure 3.B represents the predicted docking of 
EcAMP1R2 towards three membrane systems, two of them neutral (zwitterionic) and one 
anionic. The latter shows the higher number of atom-per-atom peptide-membrane 
interactions, suggesting a preference of the peptide to interact with bacterial-like models 
(unpublished data). Conversely, the membrane containing cholesterol (left) has the lowest 
score of atom-per-atom, showing that mammalian-like membranes are not the preferable 
target of this AMP, and suggesting a low toxicity to mammalian cells, as demonstrated in the 
cytotoxicity assays. 
By circular dichroism, it was seen that EcAMP1R2 shows an α-helical secondary structure 
in the presence of negatively charged lipid vesicles. The higher degree of secondary 
structuring was observed for vesicles of POPC:POPG (70/30), presenting a higher α-helix 
content, with contribution of the unstructured regions. Conversely, when the peptide is free 
in solution or in the presence of zwitterionic vesicles, it showed clearly a random coil 
behavior. These results indicate a higher affinity of EcAMP1R2 towards bacterial-like 
membranes. Regarding the vesicles that mimic the two membranes present in Gram-
A 
B 
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negative bacteria, the peptide adopted a β-sheet structure upon interaction with the inner-
membrane like (IML) vesicles, which was not expected.  
 
Figure 4. Conformational changes of EcAMP1R2 evaluated by Circular Dichroism in aqueous solution (---), 
POPC (—), POPC:POPG (70/30) (—), POPC:Chol (—), IML (—) and OML (—), with a peptide to lipid ratio of 
0.002 (unpublished data). 
 
Objectives 
The main goal of the present work was to study the membrane activity and selectivity of a 
novel synthetic antimicrobial peptide, EcAMP1R2, using biophysical approaches based on 
fluorescence spectroscopy and light scattering spectroscopy (DLS and Zeta-potential) 
techniques.  
To do so, several sub-objectives were established: 
1. Study the aggregation of EcAMP1R2 
2. Analyze the selectivity of EcAMP1R2 towards bacterial-like and mammalian-like 
membranes, following the intrinsic fluorescence of EcAMP1R2 upon interaction with 
large unilamellar vesicles.  
3. Elucidate the alterations in membrane physical properties caused by the peptide, aiming to 
get insights on the mechanistic aspects of the mode of action of EcAMP1R2.  
4.  Comparatively study the events leading to the membrane alteration in bacteria and in 
model system membranes.  
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Materials and methods  
 
1. Materials 
EcAMP1R2 peptide (purity >95%) stock solutions were prepared in Milli-Q water, filtered 
with pore size 0.2 µm, to a final concentration of 468 µM and stored at -20 ºC. POPC (1-
palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine), POPG (1-palmitoyl-2-oleoyl-sn-glycero-3-
phosphoglycerol) and POPE (1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoethanolamine), were 
obtained from Avanti Polar Lipids (Alabaster, AL, USA). Cardiolipin sodium salt from 
bovine heart (CL), cholesterol (Chol), lipopolysaccharide from Escherichia coli O26:B26 
(LPS), Luria-Bertani Agar (LB), Mueller Hinton Broth (MHB), 8-anilino-1-
nonaphthalenesulfonic acid ammonium salt (ANS), Pluronic F-127, TMA-DPH (N,N,N-
trimethyl-4-(6-phenyl-1,3,5-hexatrien-1-yl) phenylammonium p-toluenesulfonate) and DPH 
(1,6-Diphenyl-1,3,5-hexatriene) were purchased from Sigma Aldrich (St. Louis, MO, USA). 
The probes 2-dimethylamino-6-lauroylnaphtalene (Laurdan) and 4-[2-[6-(dioctylamino)-2-
naphthalenyl]ethenyl]-1-(3-sulfopropyl)-pyridinium (di-8-ANNEPS) were obtain from 
Invitrogen (Carlsbad, CA, USA). Hepes 10 mM, with NaCl 150 mM, pH 7.4, was used as 
buffer in all experiments. 
 
2. LUVs preparation 
Large unilamelar vesicles (LUVs) were used as biomembranes model systems. In Table 1 are 
summarized the different vesicles used in this work, each of them mimicking diverse 
biological membranes.  
Table 1: Lipid composition of selected model membrane systems, with their biological relevance. 
Lipid composition Biological relevance Reference 
POPC Comparison 27 
POPC:POPG (90/10) Bacteria 27 
POPC:POPG (70/30) Bacteria 27 
POPC:Chol (90/10) Mammalian 27 
POPC:Chol (70/30) Mammalian 27 
POPE:POPG:CL (63/33/4) Inner membrane of E. coli (IM-Like) 33 
POPE:POPG:CL:LPS (80/16/1/3) Outer membrane of E. coli (OM-Like) 33 
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LUVs with approximately 100 nm of diameter were prepared by extrusion48. Initially, lipids 
were dissolved in Choloroform in a round-bottomed flask. For LPS lipid film formation, LPS 
was dissolved in a mixture Choloroform/methanol 2:1 and the solution was extensively 
vortexed and bath sonicated, at 40 ºC, during 15 min. After mixing, lipids were dried under a 
stream of nitrogen, forming a thin lipid film in the flaks wall, and left overnight under 
vacuum. The dried lipid mixtures were then re-hydrated in buffer. The resulting solution was 
frozen and thawed eight times, resulting in the formation of multilamellar vesicles (MLV). 
Finally, LUVs of approximately 100 nm were obtained by extrusion, using a LiposoFast-
Basic (Avestin Europe, Mannheim, Germany). For most of the different lipids or lipid 
mixtures, extrusions were done 21 times, through a polycarbonate membrane with a pore size 
of 100 nm (Whatman, Florham Park, NJ, USA). For OML and IML vesicles, extrusion was 
done 41 times, since control size determinations by dynamic light scattering spectroscopy 
showed that a higher number of extrusion cycles was necessary to achieve the size 
distribution characteristic of LUV48. 
 
3. Bacterial culture 
An aliquot of 10 µL of Escherichia coli ATCC® 25922™, obtained from American Type 
Culture Collection (ATTC, Manassas, VA, USA), was plated on LB agar, and incubated 
overnight, at 37 ºC. An isolated colony was re-suspended into 5 mL of MHB and grown 
overnight at 37 ºC, until the log-phase state is reached. A 100 µL inoculate was transferred 
into 5 mL of fresh medium and grown 3 h, then centrifuged 4000 g, for 25 min, at 10 ºC, and 
washed three times with MHB medium. The optical density at 600 nm (O.D.600nm) of bacteria 
was adjusted in order to obtain a cell density of approximately 1×106 cells/mL49. 
4. Fluorescence spectroscopy measurements 
Fluorescence measurements were carried out in a Varian Carry Eclipse fluorescence 
spectrophotometer (Mulgrave, Victoria, Australia) equipped with a Xenon pulsed lamp. The 
spectral bandwidths of excitation and emission were of 5 nm and 10 nm, respectively. These 
bandwidths were used in all fluorescence spectroscopy studies. Fluorescence spectra were 
recorded with 0.5 cm path length quartz cells. All measurements were performed at least three 
times with independent measurements, at 25 ºC. All fluorescence spectra were corrected for 
lipid scattering and dilution effects. 
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4.1. Peptide aggregation assay by ANS  
Anilinonaphthalenesulphonates are non-fluorescent in polar environments, and become 
fluorescent when embedded in the hydrophobic core of proteins. This property makes them 
sensitive indicators of processes that modify the exposure of the probe to water, such as 
protein aggregation50. The aggregation of EcAMP1R2 was followed by measuring ANS 
fluorescence intensity, with an excitation wavelength (λexc) of 380 nm and emission 
wavelengths (λem) between 400 and 650 nm. ANS (25 µM) in buffer was titrated with a range 
of EcAMP1R2 concentrations from 0 to 30 µM. The behavior of the fluorescence intensity 
(with λem at 480 nm) against peptide concentration was analyzed, as well as possible 
displacements in the ANS emission spectrum towards lower wavelengths51. 
4.2. Partition coefficient determination 
Fluorescence techniques are among the most sensitive and very suitable when quantifying the 
partitioning of a peptide into membranes. The insertion of a fluorescent residue of a peptide in 
a lipid membrane leads to a change of its quantum yield (usually increasing)42,44,52. This 
property can be used to determine the partition constant or partition coefficient (Kp) of the 
peptide between the aqueous and the lipid phases. To study the partition of the peptide 
between the lipid and the aqueous phase, lipid mixtures of different compositions were used. 
Peptide partitioning into lipid bilayers was monitored by registering changes in the peptide 
intrinsic tryptophan fluorescence upon addition of lipid vesicles. Successive aliquots of LUVs 
were added to a peptide solution (6 µM). After each addition of small quantities of lipid (20 
mM stock solutions), the sample was incubated for 5 min before recording the emission 
spectrum. Fluorescence emission spectra between 300 and 500 nm were recorded with 
excitation at 280 nm, before and after each addition of lipid. Besides, non-partitioning free 
tryptophan was titrated under the same experimental conditions53. To quantify the extent of 
the membrane incorporation, the partition coefficient, Kp, was calculated from the fit of 
experimental data using equation 4.1 
𝐼
𝐼W
=
1+𝐾p 𝛾L
𝐼L
𝐼W
[L]
1+𝐾p𝛾L[L]
     4.1 
where IW and IL are the fluorescence intensities in the water and in the lipid phase, 
respectively,  γL is the lipid molar volume and [L] is the lipid concentration43.  
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Exceptions to the general rule of hyperbolic variation of the fluorescence intensity of a 
fluorophore as a function of lipid concentration can occur, mainly due to processes of self-
quenching upon insertion in the membrane. When such behaviors were observed, the partition 
constant was calculated using equation 4.2: 
𝐼
𝐼W
=  
𝐾p𝛾L[𝐿]𝐼L
1+𝐾p𝛾L[𝐿]+𝑘2𝐾p𝐼L
+ 
𝐼𝑤
1+𝐾p𝛾L[𝐿]
 4.2 
where k2 is proportional to the ratio between the bimolecular self-quenching rate and the 
radiative decay rate54.  
 
5. Fluorescence quenching assays 
The exposure of the Trp residue to the aqueous environment was evaluated by fluorescence 
quenching with acrylamide. Acrylamide is a small polar molecule commonly used as a 
tryptophan quencher42. Lipid bilayers are impermeable to acrylamide molecules because of its 
polarity. Hence, the fluorescence of a Trp residue inserted in a membrane system is not 
susceptible of being quenched by acrylamide molecules. Conversely, if quenching occurs, one 
can infer that the Trp residue was not inserted into the hydrophobic core of the lipid bilayer42. 
Successive aliquots of acrylamide (1 M) were added to a peptide solution in the absence and 
presence of vesicles ([L] = 3 mM). Emission of tryptophan was monitored between 305 and 
500 nm after excitation at 290 nm, in order to minimize the quencher/fluorophore light 
absorption ratios. The extension of linear quenching of the tryptophan residue was quantified 
using the Stern-Volmer equation (5.3): 
𝐼0
𝐼
= 1 + 𝐾𝑆𝑉[𝑄]      5.3 
where I0 is the fluorescence intensity of the peptide measured in the absence of the quencher, I 
is the fluorescence intensity at a given quencher concentration, Q is the concentration of 
quencher (acrylamide), and KSV the Stern-Volmer constant.  
When a negative deviation to linear behavior is observed, experimental data were fitted using 
equation 5.4:  
𝐼0
𝐼
=
1 + 𝐾𝑆𝑉 [𝑄]
(1 + 𝐾𝑆𝑉[𝑄])(1−𝑓𝐵) + 𝑓𝐵
    5.4 
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where fB is the fraction of light arising from the fluorophores accessible to the quencher
55. 
 
6. Membrane probes 
The use of fluorescence spectroscopy in the study of peptide-membrane interactions may 
follow two approaches. When the peptide has at least one tryptophan residue, it is possible to 
follow its intrinsic fluorescence, which is very informative since it is highly dependent on 
variations in its surrounding microenvironment42. Nonetheless, this approach cannot be used 
when the aim is to characterize the interactions of peptides with cell membranes. Cells are 
rich in proteins, most of them containing tryptophan residues, thus, unabling a proper 
following of the intrinsic fluorescence of the peptide. In the present study, sensitive probes 
were used as reporters of variations in membrane properties. These probes undergo some 
physical changes that are measurable by monitoring their spectral characteristics. In this 
study, four fluorescent probes (see below) were assessed to monitor the effect of EcAMP1R2 
on several physical-chemical properties of the membranes, both in model membranes and in 
E. coli cells.  
LUVs assays with the fluorescent probes were carried out following this general scheme, with 
some variations in the case of the probe di-8-ANEPPS. Vesicles obtained by extrusion were 
labeled with the desired probes, with a probe to vesicle ratio of 1:300, and with a final 
concentration of lipid of 3 mM, unless otherwise indicated. The labeling process was 
performed with constant agitation for 30 min (60 min for di-8-ANEPPS). After labeling, 
aliquots of peptide were added to the mixture and incubated for 1 h.   
Bacteria studies with fluorescent probes followed a similar general scheme. A suspension of 
E. coli washed three times with MHB medium and a cell density adjusted to 1 × 104 cells/mL. 
Then, cells were labeled with the probe to a final dye concentration of 10 µM (100 µM for di-
8-ANEPPS in bacteria), during 30 min in the dark (60 min for di-8-ANEPPS). After labeling, 
successive aliquots of increasing concentrations of peptide were added, in a range of 0 to 20 
µM and incubated for 1 h. 
6.1 Laurdan assay 
Laurdan is a solvatochromic fluorescent dye, whose emission spectrum is highly sensitive to 
the level of water penetration into the lipid bilayer. This makes Laurdan very suitable in the 
evaluation of changes in the lipid order (or packing) of membranes. Hence, possible changes 
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in the packing of lipids in bacterial cell membranes and in model membranes upon addition of 
peptide were monitored using Laurdan. Labeled samples were excited at 350 nm, and the 
emission spectrum between 400 and 600 nm was recorded. To quantify the spectral changes, 
the Laurdan generalized polarization (GP) was calculated as follows: 
GP =  
𝐼440− 𝐼490
𝐼440+ 𝐼490
    6.5 
where I440 and I490 are the intensities at λem 440 and 490 nm, respectively56.  
6.2 DPH and TMA-DPH assays 
Changes in the fluidity of the used model membranes and bacteria cells, due to the action of 
the peptide were followed monitoring the anisotropy of the fluorescent probes DPH and 
TMA-DPH, at 25 ºC.  
Polarization measurements are based in the principle of photo-selective excitation of 
fluorophores by polarized light (i.e. fluorophores preferentially absorb photons whose electric 
vectors are aligned parallel to their transition moment). Polarization measurements reveal the 
average angular displacement (rotational rate) of the fluorophore that occurs between 
absorption and subsequent emission of a photon. In the context of membranes, the rotational 
rate of a fluorophore is dependent on the fluidity of the bilayer, thus, a change in the fluidity 
of membranes will result in alterations in fluorescence anisotropy, being higher in bilayers in 
the gel phase and lower in liquid-crystal state membranes (less and more fluid membranes, 
respectively)42. Due to their location in the membrane, DPH assesses the fluidity at the 
hydrophobic core of the lipid bilayer, namely at the level of the fatty acid chains of the 
phospholipids, while its cationic derivative TMA-DPH anchors to the water/lipid interface, 
reporting the fluidity closer to the membrane surface57. 
Fluorescence anisotropy measurements of the samples were conducted as a function of the 
concentration of peptide, using a λexc of 350 nm and a λem of 432 nm in the case of DPH and a 
λexc 355 nm and a λem of 432 nm for TMA-DPH. Anisotropy (r) values were calculated using 
equation 6.6: 
𝑟 =  
𝐼VV− 𝐺 𝐼VH
𝐼VV+2 𝐺 𝐼VH
      6.6 
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where IVV and IVH are the fluorescence intensities when the angle between excitation and 
emission polarizers are 0º (vertical) and 90º (horizontal), respectively, and G is the ratio of the 
sensitivities of the detection system for vertically and horizontally polarized light 42, being 
determined by 
𝐺 =  
𝐼HV
𝐼HH
      6.7 
where IHV is the fluorescence intensity with horizontally polarized excitation and vertically 
polarized emission, while IHH is the fluorescence intensity with horizontally polarized 
excitation and emission. 
6.3 Di-8-ANEPPS assay 
Dipolar potential of membranes originates from the alignment of the polar heads and glycerol-
ester regions of lipids and oriented water molecules hydrating the outer surface of the 
membrane58. Peptide insertion and electrostatic interaction will perturb the membrane dipolar 
potential, which can be monitored by means of a spectral shift in the excitation spectra of the 
probe di-8-ANEPPS. This dye incorporates in the outer leaflet of the membranes, and is 
sensitive to the local dipole potential by shifting its excitation spectrum59,60. Thus, changes in 
the dipole potential due to the interaction of EcAMP1R2 with model membranes (bacteria and 
LUVs) were assessed using the dye di-8-ANEPPS.  
In the case of E. coli, the cell suspension was prepared in buffer supplemented with 0.05 % 
Pluronic F-127 yielding a final cell density of 105 cells/mL. Then, this suspension was labeled 
with the dye (final concentration of 100 µM). Labeled cells were incubated for 1 h, after 
which aliquots of peptide were added and the excitation spectra measured with a λem of 670 
nm. The effect of the peptide over the dipole potential was quantified using the ratio of 
fluorescence intensities at 455 nm and 525 nm (R)60. The ratio R allows a quantitative 
analysis of the variation of the dipole potential, by quantifying the shift in the excitation 
spectrum. The experimental results from the measurements as a function of EcAMP1R2 
concentration were fitted to equation 6.8: 
𝑅
𝑅0
=  
𝑅𝑚𝑖𝑛
𝑅0
 [P]
𝐾d+[P]
       6.8 
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with R values normalized for R0, the value without addition of peptide, and being Rmin the 
minimum asymptotic value for R and Kd the apparent dissociation constant
58. 
 
7. Light scattering spectroscopy 
Light scattering measurements were carried out in a Malvern Zetasizer Nano ZS (Malvern, 
UK) with a backscattering detection at a constant scattering angle of 173º, equipped with He-
Ne laser (λ = 632.8 nm). The samples were left equilibrating for 15 min at 25 ºC. 
Measurements were performed three times except for IML and OML LUVs, which were 
assessed twice. 
7.1 Dynamic light scattering measurements 
AMPs can induce membrane aggregation and even membrane fusion61. Vesicle aggregation is 
driven by electrostatic forces exerted by oppositely charged peptides, and has been profusely 
studied due to its theoretical, biological and biotechnological interest61. Thus, changes in the 
size distribution of LUVs due to the addition of the peptide EcAMP1R2 were determined by 
Dynamic Light Scattering (DLS).  
The measured diffusion coefficient (D) values were used for the calculation of the 
hydrodynamic diameter (DH), through the Stokes-Einstein relationship: 
𝐷 =
𝜅𝑇
3𝜋𝜂DH
     7.9 
where η is the dispersant viscosity, κ the Boltzmann constant and T the absolute temperature. 
The hydrodynamic diameter was obtained from an average taken from 15 measurements with 
10 runs each62. 
For the measurements, 1 h before, aliquots of EcAMP1R2 were added to a suspension of 
vesicles with a concentration of 200 µM diluted in HEPES buffer (pH 7.4). Buffer was 
previously filtered with nylon filters with a pore diameter of 100 nm, in order to reduce the 
amount of particles that could contribute for the scattering of the sample. 
7.2 Zeta-potential measurements 
Charged particles in a suspension (e.g. vesicles, cells or nanoparticles) attract ions to their 
surface, forming a layer denominated the Stern layer. Outside the Stern layer, there is another 
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layer where ions diffuse more freely. Within this diffuse layer there is a notional boundary 
inside which the particle forms a stable entity. In the presence of an electric field, the particle 
moves and the ions within this boundary move along with it. Conversely, ions beyond do not 
move concomitantly. The electric potential that exists at this boundary is called the zeta 
potential (ζ). This potential can be determined by measuring the electrophoretic mobility of 
the particles in solution towards the electrode of opposite charge in the presence of an electric 
field62. 
In order to evaluate the changes in the surface charge, ζ measurements were performed in E. 
coli cells and LUVs using disposable folded capillary cells with golden electrodes (Malvern, 
UK). Successive aliquots of peptide were added into solutions containing either bacteria (1 x 
106 cells/mL) or LUVs (200 µM) diluted in filtered HEPES buffer. These suspensions were 
incubated during 1 h before the measurements. The viscosity and refractive index values were 
set to 0.8872 cP and 1330, respectively, and the electric field was 40 V. The electrophoretic 
mobility values allowed us to calculate the zeta-potential (ζ) using the Smoluchowski 
equation:  
 =
4𝜋𝑣𝑢
𝜀
     7.10 
where u is the electrophoretic mobility, ε is the dielectric constant and  is the molar 
volume62. Each zeta-potential value was obtained from an average of 15 measurements with 
100 runs each. 
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Results and discussion 
 
1. Peptide aggregation studies 
Because EcAMP1R2 is a synthetic rationally-designed peptide, its tendency to form 
aggregates ought to be assessed, since ignored peptide aggregation would lead to 
misinterpretation of further results. Hydrophobic interactions have a great contribution in the 
early stage of protein aggregation63. We took advantage of this feature using ANS, a 
fluorescent dye that binds to the hydrophobic pockets in protein aggregates. When ANS is 
buried in an hydrophobic environment, its quantum yield (assessed through fluorescence 
intensity measurements) increases, and its emission spectrum undergoes a blue shift51. Figure 
5A shows the normalized fluorescence spectra of ANS at three different peptide 
concentrations. Neither blue shift was observed, nor the titration of EcAMP1R2 with ANS 
caused an increase on the fluorescence intensity (Figure 5B), suggesting that aggregation of 
EcAMP1R2 does not occur in the experimental conditions used.  
 
 
Figure 5. Aggregation studies of EcAMP1R2 by ANS fluorescence (A) Fluorescence intensity of ANS (λexc = 
380 nm, λem = 480 nm) spectra at three different EcAMP1R2 concentrations: — 0 µM; — 11.7 µM; — 30 
µM. (B) Normalized fluorescence intensity at different peptide concentrations.  
 
2. Membrane incorporation studies with LUVs: characterization of the 
selectivity of EcAMP1R2 
AMPs are known for usually having membranes as their primary cellular target34. Their 
selectivity against bacterial membranes is generally determined by electrostatic-driven 
A B 
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interactions between the negatively charged polar heads of the phospholipids and the cationic 
residues of the peptide. These electrostatic interactions are generally weaker with mammalian 
cell membranes, given the zwitterionic nature of the lipids that make up the outer leaflet of 
these membranes12.  
The determination of the partition coefficient is a starting point in the characterization of 
interactions between AMPs and model membrane systems43. By doing this, it is possible to 
address the selectivity of the peptide towards bacterial-like membranes, and the extent to 
which the electrostatic interactions are important for the internalization of the peptide. Being 
both sensitive and noninvasive, fluorescence spectroscopy-based techniques are convenient to 
measure the partitioning of peptides that bear an intrinsic fluorescent residue. In general, the 
quantum yield of a tryptophan residue increases when it incorporates into a hydrophobic 
environment (e.g. when it incorporates into the non-polar core of a lipid bilayer)42. This 
feature allows the determination of the partition coefficient, Kp, using equation 4.1 for the 
fitting to the experimental data43,44. Thus, we can quantitatively evaluate the membrane 
selectivity of EcAMP1R2, by determining its partition to vesicles with diverse lipid 
compositions. The LUVs tested intended to mimic the membranes of mammalian cells, a 
general model for bacterial cells, and the outer and inner membranes of Escherichia coli (here 
abbreviated as OML and IML, respectively). Mammalian cell membranes are rich in neutral 
phospholipids (such as POPC) and have cholesterol as a distinctive sterol29. On the other 
hand, bacterial cells in general are negatively charged, with variable concentrations of anionic 
lipids such as POPG or cardiolipin64.  
Figure 6 shows the partition curves obtained by following the intrinsic fluorescence of 
EcAMP1R2 upon addition of successive aliquots of LUVs of pure POPC, POPC:POPG 
(90/10 and 70/30), POPC:Chol (90/10 and 70/30), IML and OML (see Table 2). Moreover, 
Table 2 shows the partition parameters obtained, Kp and IL/IW, for EcAMP1R2, as well as the 
values of blue shift. Here, the blue shift of the emission spectrum towards lower wavelengths 
occurred when tryptophan incorporates into less polar environments42. The parameter IL/IW is 
the ratio between the intensity of the peptide in the lipid and in the water phase. It reflects the 
change of the fluorescence quantum yield of the tryptophan upon membrane insertion, 
providing thus valuable information54.  
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Figure 6. Partition curves of EcAMP1R2 (6 µM) in five different membrane model systems: ● POPC; ● 
POPC:POPG (90/10); ▼ POPC:POPG (70/30); ● POPC:Chol (90/10); ● POPC:Chol (70/30); ● IML; ● OML. 
Lines depicted represent the adjustment of the experimental data to Equation 4.1, in the case of POPC, 
POPC:POPG (90/10 and 70/30), POPC:Chol (90/10 and 70/30) and OML vesicles. Non-hyperbolic behaviors 
(due to self-quenching processes) were adjusted to the Equation 4.2, only for IML vesicles. Fitted parameters are 
summarized in Table 2. 
 
Table 2. Partition parameters and blue shift values of the peptide for each membrane model system. Values are 
presented as mean ± standard error (SE) 
Lipid composition Kp IL/IW Blue shift (nm) 
POPC 2617 ± 741 1.14 ± 0.01 0 
POPC:POPG (90/10) 508 ± 222 1.60 ± 0.15 1 
POPC:POPG (70/30) 1801 ± 284 2.15 ± 0.06 11 
POPC:Chol (90/10) 1794 ± 573 1.27± 0.03 0 
POPC:Chol (70/30) 948 ± 345 1.21 ± 0.04 0 
Inner-like 21798 ± 8485 - 5 
Outer-like 101 ± 95.92 4.63 ± 2.969 8.5 
 
The quantum yield of the tryptophan increased upon titration with most lipid compositions. 
An exception to this is observed for the vesicles mimicking the inner membrane of E. coli 
(IML). A plausible explanation for this is that, after interaction with membranes, the Trp 
residue could suffer self-quenching (due to the low lipid concentration) or quenching induced 
by the microenvironment where it is inserted. Considering that all systems tend to reach an 
equilibrium, initially, the amount of tryptophan available for interaction can be higher than 
usual, leading to a two-phase behavior. Also, the fact that the neighboring amino acids are 
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mostly lysine residues, whose side chains are natural quenchers for Trp, can be an additional 
cause for this exception42. In this case, the partition constant was determined using equation 
4.2, obtaining the highest Kp compared to the other lipid compositions (see Table 2). 
Unexpectedly, we obtained a high Kp in pure POPC vesicles. However, some facts question 
the validity this value. First, regarding IL/IW, the low value of this parameter indicates that 
most peptide remains in the water phase. As a result, an accurate fitting becomes hard to 
accomplish, yielding elevated errors. As a matter of fact, standard error represents 28 % of the 
Kp value calculated. Besides this, no blue shift was observed. This explanation also applies to 
the similar situation that we see in the case of POPC:Chol (90/10) vesicles, in which high Kp 
is associated to an error of 32 %. The Kp obtained for EcAMP1R2 in POPC:POPG (70/30) 
vesicles is among the highest values and a significant blue shift was observed. However, the 
Kp of the POPC:POPG (70/30) vesicles was lower than for IML. This might be caused by 
differences in composition, since specific membrane constituents might alter the affinity of 
the AMP (See Introduction Section 2). In this case, both POPE and CL (zwitterionic and 
anionic, respectively) might be playing an important role in such improvement in the affinity 
of EcAMP1R2. In contrast, POPC:POPG (90/10) mixtures (slightly anionic) displayed a low 
Kp and a low displacement of the emission spectrum. Finally, we obtained a very low Kp when 
studying the interaction of the peptide with OML, with a significant error associated. The 
reason to this is that the equation could hardly fit the experimental results, which followed a 
close-to-linear behavior. In spite of this, blue shift was observed, implying that interaction 
actually occurred. Moreover, supporting this idea is the fact that this mixture displayed the 
highest IL/IW value.  
All in all, the results aim to a low interaction of EcAMP1R2 with zwitterionic (neutral) lipids, 
but further tests were needed to elucidate this question. On the other hand, partition studies 
with EcAMP1R2 aim to a higher affinity towards the composition containing POPE and CL 
(i.e. those that mimic the inner membrane of E. coli), highlighting the importance of the use 
of realistic membrane model systems.  
 
3. Exposure of the tryptophan residue to the aqueous environment 
Fluorescence events are very informative about the microenvironment of a given fluorophore. 
Complementary to the membrane incorporation studies, quenching assays were performed. 
Because membranes are impermeable to acrylamide, the fluorescence of a tryptophan residue 
 [23]  
 
fully inserted in a membrane is not susceptible of being quenched by acrylamide. Conversely, 
when an acrylamide molecule encounters with Trp, collisional (or dynamic) quenching 
occurs, hindering the fluorescence emission42. Figure 7 shows the Stern-Volmer plots 
obtained for EcAMP1R2 in the absence and presence of vesicles. Stern-Volmer constants 
(KSV) were calculated fitting the linear plots using equation 5.3, or using equation 5.4 when a 
nonlinear behavior was observed. KSV values are presented in Table 3.  
 
Figure 7. Stern-Volmer plots for EcAMP1R2 (6 µM) in aqueous solution (●), pure POPC (●), POPC:POPG 
(70/30) (▼), POPC:Chol (●), IML (●) and OML (■), at constant lipid concentration (3 mM). Solid lines 
represent the fitting of the data to Equation 5.3 in case of the aqueous solution, pure POPC and POPC:Chol 
(70/30), or Equation 5.4 in the case of POPC:POPG (70/30), IML and OML vesicles. Fitted parameters are 
summarized in Table 3. 
 
Table 3: Parameters obtained for the quenching of EcAMP1R2 by acrylamide in aqueous solution (free) and in 
the presence of lipid vesicles. 
Lipid composition KSV (M
-1) ± S.E. fB 
Aqueous solution 34.8 ± 1.7 - 
POPC 34.1 ± 2.5 - 
POPC:POPG (70/30) 18.6 ± 4.2 0.047 
POPC:Chol (70/30) 27.5 ± 3.6 - 
IML 9.4 ± 0.7 0.028 
OML 13.1 ± 3.2 0.066 
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High values of KSV are indicative of an efficient quenching of tryptophan fluorescence by 
acrylamide (a collisional quencher). As expected, the highest value of KSV was obtained for 
the free peptide. An almost equal value was observed in pure POPC vesicles, followed by 
POPC:Chol (70/30). These results indicate that a low internalization of the tryptophan residue 
occurs in the presence of zwitterionic vesicles, and hence, can be used as a counterbalance of 
the partition results. The lowest KSV was obtained for IML vesicles, in good agreement with 
what was found in the partition experiences. Low KSV values were also obtained for OML 
vesicles, indicating that EcAMP1R2 hides strongly from the quencher molecule. Also, a 
foreseeable low KSV was observed for POPC:POPG (70/30) vesicles, corroborating a strong 
peptide-membrane interaction. Interestingly, we found non-linear behaviors in the three 
anionic model membrane systems analyzed. Nonlinear Stern-Volmer plots are indicative that 
two sub populations are present, each of them with different accessibility to the quencher. 
This means that the peptide reached a stagnation in the incorporation in the membrane, being 
one population protected and the other staying accessible to the collisional quencher. All 
results together show that EcAMP1R2 has a high affinity only towards anionic membranes. 
 
4. Changes in membrane properties: lipid fluidity, lipid packing and 
dipole potential. 
We assessed four fluorescent membrane probes that provide information about three major 
properties of membranes: lipid order or packing, microviscosity or fluidity, and the dipole 
potential. The aim of this is to infer some functional information about EcAMP1R2 action. 
Besides, membrane probes are not cytotoxic allowing us to analyze the properties of 
membranes in biological samples. Therefore, in addition to the vesicles with various 
compositions (pure POPC, POPC:POPG (70/30), POPC:Chol (70/30), IML and OML), we 
also analyzed the disturbance caused by EcAMP1R2 in membranes of E. coli cells. This 
enables the comparison of the results obtained with model membrane systems, with those 
obtained for living cells. However, cell membranes are dynamic and heterogeneous systems, 
sometimes hindering the reproducibility of the experiences. Moreover, the two membranes of 
E. coli cells add more difficulties to the correct interpretation of the results. That is why, in 
spite of their simplicity, model membranes systems such as LUVs are convenient for these 
studies, in addition to the possibility of testing with them biomembrane models with different 
lipid compositions.  
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4.1 Changes in membrane packing assessed by generalized polarization 
Being sensitive to the hydration level of lipid bilayers, Laurdan is useful when it comes to 
measure the lipid packing of membranes, allowing us to observe changes that occur in terms 
of lipid rearrangement. The emission maximum of Laurdan is near 440 nm in gel-phase 
membranes (more packed) and near 490 nm in liquid phase membranes (less packed)65. 
Generalized polarization (GP, see equation 6.5) relates quantitatively these spectral changes. 
Membranes with less packed lipids will have a GP value closer to -1, while those with GP 
values closer to +1 will have more tightly packed lipids. Figure 8 shows GP values upon 
increasing concentrations of EcAMP1R2, for different lipid compositions.  
 
 
Figure 8. Generalized polarization of Laurdan (9.9 µM) as a function of EcAMP1R2 concentration for POPC 
(●), POPC:POPG (70/30) (▼), POPC:Chol (70/30) (●), IML (●), OML (●), and E. coli cells (●). Lipid 
concentration was kept constant at 3 mM, and cell density was 1×105 cells/mL. 
Initially, considering the GP value for the different membranes tested without the presence of 
peptide, pure POPC, POPC:POPG (70/30) and E. coli were the samples with less packed 
membranes, while POPC:Chol, OML were the more tightly packed membranes, with the IML 
membrane showing an intermediate value, among the systems tested. Cholesterol acts as a 
fluidity and packing buffer66,67. Hence, we interpret that the loosely packed LUVs of pure 
POPC have been condensed by the presence of cholesterol. The high packing showed by 
OML vesicles might be due to the presence of LPS, which forms highly packed domains68. 
Besides, the anionic phospholipid POPG has a vesicle-condensing ability, as it can be 
deduced by the differences found in GP between pure POPC vesicles and POPC:POPG 
mixtures, being the latest one more packed. POPG is also a major component of IML (33 %), 
explaining the high values of GP. Moreover, POPE:POPG mixtures have been reported to 
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increase membrane packing due to the POPG umbrella effect that promote the small 
ethanolamine of POPE to slip underneath the large glycerol head group69. The difference of 
lipid order observed between IML and OML vesicles, besides the LPS presence in the latter, 
might be due to the higher concentration of CL in IML vesicles. High concentrations of CL 
are known to increase membrane fluidity and decrease lipid packing 70.  
Apparently, the interaction of EcAMP1R2 caused little or no changes in the lipid packing of 
the vesicles, as shown in Figure 7. Although there is an apparent increase in the lipid order of 
E. coli membranes as the peptide concentration increases, statistical analysis showed no 
significant differences between the initial and last concentration tested. The increased 
complexity of biological samples, structural changes, physiological variations, and 
acclimatization processes can cause higher deviations than studies with membranes systems. 
EcAMP1R2 caused a slight increase in the GP of IML vesicles, reporting an increase in its 
lipid packing, whereas no effect was observable in OML. The insertion of EcAMP1R2 also 
causes a thickening in POPC:POPG (70/30) LUVs. A plausible explanation to this could be 
that the partition of the peptide into the core of the membrane could cause the exclusion of 
some water molecules in this area. However, this question will be further addressed, taking 
into account the overall changes caused by EcAMP1R2. 
 
4.2 Changes in membrane fluidity assessed fluorescence anisotropy 
Anisotropy measurements provide information about the rotational diffusion of the 
fluorophore. The rotational rate of fluorophores in membranes depend on membrane fluidity. 
Thus, the effect in membrane fluidity of vesicles and E. coli cells upon successive additions of 
EcAMP1R2 was evaluated by monitoring the fluorescence anisotropy of DPH and TMA-
DPH, as shown in Figure 9.  
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Figure 9. DPH (A) and TMA-DPH (B) fluorescence anisotropy as a function of EcAMP1R2 concentration for 
POPC (●), POPC:POPG (70/30) (▼), POPC:Chol (70/30) (●), IML (●), OML (●) and E. coli cells (●). Lipid 
concentration was kept constant (3 mM), probe concentration was 9.9 µM and cell density 1×105 cells/mL.  
  
Attending to the DPH anisotropy, in the absence of peptide, vesicles of POPC:POPG (70/30) 
showed the lower anisotropy values, followed by pure POPC vesicles. Lower anisotropy 
values are associated to a smaller restriction of rotation of the probe and, as a consequence, 
they correspond to membranes with higher fluidity. Thus, the most rigid LUVs were 
POPC:Chol (70/30), followed by E. coli cells and OML vesicles.  
The anisotropy of TMA-DPH showed a similar pattern, with OML, POPC:Chol (70/30) and 
IML being the most rigid vesicles. These results are consistent with what was observed using 
Laurdan generalized polarization, given the close relationship between membrane fluidity and 
packing. Apparently, LUVs containing cholesterol or POPE are more packed and rigid, 
whereas increasing concentrations of CL are associated to higher fluidity and lower packing. 
Anisotropy results obtained for E. coli were close to 0.16 for DPH and 0.17 for TMA-DPH; 
but, once again, high standard deviations were associated to cell experiments. As to the effect 
of the peptide in fluidity, it did not exert significant changes neither in vesicles nor in bacterial 
cells, at least at the experimental conditions tested.  
 
4.3 Changes in dipole potential  
Di-8-ANEPPS was used to evaluate the effect of EcAMP1R2 in the dipole potential of 
vesicles with different lipid compositions and E. coli cells. In order to quantify the interaction, 
we measured the ratio R for a range of peptide concentrations, as shown in Figure 10. This 
A B 
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ratio allows a quantitative analysis of the relative variation in dipole potential58. Moreover, 
from these results, it is possible to determinate the dissociation constant (Kd) by fitting the 
values to the equation 6.8. In this case, Kd is an apparent dissociation constant that describes 
the affinity of the peptide towards the membrane. Thus, larger values of Kd are interpreted as 
lower interactions. Kd values for the different vesicles tested and in E. coli cells are detailed in 
Table 4, as well as the values of ΔR, which is defined as the difference between R0 (R in the 
absence of peptide) and Rmin (i.e. the asymptotic minimum value of R). 
 
 
Figure 10. Dipole potential variation as a function of EcAMP1R2 concentration in POPC (●), POPC:POPG 
(70/30) (●), POPC:Chol (70/30) (▲), IML (●), OML (●) and E. coli cells(●). Lipid concentration was kept 
constant (200 µM) and E. coli cells were tested at 1×105 cells/mL. Depicted lines represent the adjustment of the 
experimental data to Equation 6.8. Fitted parameters are summarized in Table 4. 
 
Table 4: Peptide dissociation parameters by means of di-8-ANEPPS depolarization. 
Lipid composition Kd   ± S.E. (µM) ΔR 
POPC 5.91 ± 5.23 -0.01 
POPC:POPG (70/30) 15.18 ± 2.64 -0.23 
POPC:Chol (70/30) 4.51 ± 3.13 -0.01 
IML 13.38 ± 3.70 -0.26 
OML 5.89 ± 1.03 -0.12 
E. coli 1.66 ± 0.49 -0.39 
 
An analysis of Figure 10 suggests that there is no change in the dipole potential of 
zwitterionic vesicles (i.e. pure POPC and POPC:Chol (70/30)). This idea is supported by the 
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close to zero values of ΔR (Table 4). Even with the relatively low Kd values obtained through 
the fitting, these should be rejected due to the high error associated to these vesicles. In 
contrast, EcAMP1R2 induced depolarization of the OML, IML and POPC:POPG (70/30) 
vesicles, with Kd values of 5.89, 13.38 and 15.18 µM, respectively. The depolarization caused 
by EcAMP1R2 in OML vesicles suggests a strong interaction, when compared to IML and 
POPC:POPG (70/30) vesicles. These last two show similar Kd values, implying that the 
peptide modifies similarly their dipole potential, and thus, that the extent to which the peptide 
interacts with them is alike. Interestingly, the greatest change in the membrane dipole 
potential induced by EcAMP1R2 was observed in E. coli cells (Kd = 1.66 µM). We can 
consider that the extent to which the peptide interacts with membrane is comparable to the 
extent to which the peptide disturbs its dipole potential58. The rationale behind that is that the 
interaction between the peptide and membrane causes a distortion in its dipole potential, 
enabling to infer the affinity and strength of interaction of the peptide with E. coli cells, 
comparing the results obtained with cell membranes to those obtained with LUVs. In our 
case, the dissociation constant of the peptide to the cell membranes was 9 fold lower than for 
POPC:POPG (70/30) vesicles, having then a higher affinity for E. coli. Conversely, the much 
lower difference between OML and E. coli, suggests a big contribution of LPS in the 
interaction between peptide and membranes. Comparing these to the IML vesicles, it is LPS 
what mainly differentiates OML from IML.  
These results can also be used to validate the results obtained in the partition studies. It 
confirms that EcAMP1R2 selectively interacts with anionic vesicles, while the interactions 
with zwitterionic compositions are weak or negligible, in good agreement to the quenching 
assays. The big differences found between the results in E. coli cells and vesicles could 
mislead us to consider unreliable the data yielded with the chosen model membrane systems. 
However, it has to be taken into account that the results obtained with LUVs are 
representative of the interactions that happen between peptide and the lipids present in 
membranes. Still, bacteria cell membranes have a higher complexity, with diverse membrane 
proteins and other molecules that may improve the initial electrostatic interaction, hence 
translating into bigger differences in the dipole potential.  
Overall, the membrane probes has corroborated that EcAMP1R2 has a selectivity towards 
bacterial-like anionic membranes, as it can be inferred by the fact that only these membranes 
have significant changes in the different properties studied. In some cases, the interaction of 
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the peptide with the membranes causes a slight increase in membrane packing, but no changes 
in lipid fluidity have been observed. This probably could imply an internalization of the 
peptide into the hydrophobic core. This possibility is in good agreement with what was 
observed in collisional quenching studies. A deep internalization could competitively displace 
water molecules to the outside bulk (leading to an increase in Laurdan's GP), without 
interfering in the fluidity of the membrane. Nonetheless, this is just a hypothesis and more 
experiences are needed to support these findings.  
 
5. Zeta-potential of vesicles and E. coli in the presence of EcAMP1R2 
Initial interactions between AMPs and membranes (namely adsorption) are driven by 
electrostatic forces. Zeta-potential determination can be used to evaluate and validate the 
contribution of electrostatic forces to these interactions71,72. In this study, being EcAMP1R2 a 
cationic peptide, it is of major importance to analyze the differences induced in the surface 
charge of the membrane systems. Thus, we performed zeta-potential measurements using 
vesicles suspensions and E. coli cells, in the absence and presence of EcAMP1R2 (Figure 11).  
 
 
Figure 11. Zeta-potential variation as a function of EcAMP1R2 concentration for POPC (●), POPC:POPG 
(70/30) (●), POPC:Chol (70/30) (▲), IML (●), OML (●) and E. coli (●). Lipid concentration was kept constant 
at 200 µM and E. coli at 1×105 cells/mL. 
 
In the absence of peptide, IML vesicles displayed the highest (in absolute value) zeta-
potential (ζ0) value (-34.05 ± 1.12), followed by POPC:POPG (70/30) (ζ0 = -29.26 ± 0.65 mV) 
and OML vesicles (ζ0 = -15.88 ± 1.41 mV). On the other hand, zwitterionic vesicles [pure 
POPC and POPC:Chol (70/30)] showed values close to 0, as expected, as lipids that make up 
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these vesicles are all zwitterionic. Interestingly, the titration with EcAMP1R2 did not provoke 
changes in the zeta-potential, indicating no interaction with these vesicles. This result is in 
accordance with those found in previous assays. Further addition of peptide caused a slight 
depolarization in OML vesicles, recording at the maximum peptide concentration (20 µM) a 
zeta-potential (ζ20) of -12.07 ± 0.003 mV. In turn, IML vesicles showed a zeta-potential 
response of two phases after EcAMP1R2 addition. Low concentrations of EcAMP1R2 (5 µM) 
caused a noticeable depolarization response. However, from this concentration on, the 
alteration in the zeta-potential reaches a response plateau that is maintained in the range of 
concentrations studied. In the case of POPC:POPG (70/30) vesicles, change in the surface 
charge due to increasing concentrations of added EcAMP1R2 followed a linear response, but 
did not reach a complete neutralization in the range of concentrations studied.  
In the absence of peptide, E. coli cells displayed a zeta-potential of -20.13 ± 1.33 mV. The 
addition of increasing concentrations of EcAMP1R2 caused a slight neutralization on the 
membrane surface charge, with a behavior similar to OML vesicles. In addition, the Kd values 
obtained for OML and E. coli cells in the di-8-ANEPPS assays were also similar to those 
from the other vesicles. This behavior suggests a major role of LPS in peptide-bacteria 
affinity. 
The analysis of the zeta-potential results allows us to infer some additional valuable 
information. Interestingly, EcAMP1R2 concentrations above the MIC (11.7 µM) do not 
neutralize completely E. coli cells. This could mean two things: either the peptide reaches 
somehow the periplasmic space, acting thereafter in the inner membrane, or it internalizes 
deeply in the outer membrane, causing little surface neutralization. The peptide has shown 
more affinity towards the IML vesicles in the partition and quenching experiences, which 
could lead to think that the peptide surpasses the cell wall, acting at the inner membrane. Still, 
the question would be how does the peptide reach the periplasm. On the other hand, some 
other facts support the idea of a profound penetration into the outer membrane. Firstly, the 
zeta-potential behavior of OML vesicles and E. coli cells is very similar, and EcAMP1R2 has 
shown to interact with model membranes mimicking the outer membrane. The integrity of the 
outer membrane is essential, and its disruption would irretrievably lead to cell death. 
However, the argument of the internalization has also a counteract. Such internalization 
presumably would have consequences in the lipid fluidity or packing of the membranes, and 
these properties remained unaffected in OML membranes.  
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In the case of the POPC:POPG (70/30) mixture, if we assume that the linear behavior of 
charge carries on, the expected concentration of peptide in which neutralization of the vesicles 
is achieved would be 50 µM. Manzini et al.73 developed a work with an AMP with a net 
charge of +5 (such as EcAMP1R2). In that work, they reported a neutralization of 
POPC:POPG (70/30) vesicles at a peptide-to-lipid ratio of 0.1. In contrast, assuming linearity 
in the zeta-potential of EcAMP1R2 in the presence of POPC:POPG (70/30), depolarization 
would happen at peptide to lipid ratio of 0.25. Thus, these differences might give some force 
to the hypothesis of peptide internalization.  
 
6. Studies of vesicle aggregation induced by EcAMP1R2 
The action of AMPs can promote aggregation of charged vesicles, usually associated with an 
electroneutralization of surface charge that leads to a decrease of colloidal stability62,74. 
Therefore, in the absence of peptide, no aggregation is expected, since the negative charges of 
the lipid headgroups would repeal each other. On the other hand, the presence of cationic 
peptides allows short-range interactions between the lipid membranes75. The ability of 
EcAMP1R2 to induce vesicle aggregation was studied using dynamic light scattering (DLS). 
Variations in vesicle size are summarized in Figure 12. 
 
Figure 12. Alterations in the hydrodynamic diameter as a function of EcAMP1R2 concentration for POPC (●), 
POPC:POPG (70/30) (●), POPC:Chol (70/30) (▲), IML (●), OML (●). Lipid concentration was kept constant at 
200 µM. 
In all cases, the size of the vesicles in the absence of peptide showed a low polydispersity. 
The average hydrodynamic diameter for POPC:POPG (70/30), OML and IML vesicles was 
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approximately 115 nm, while pure POPC and POPC:Chol (70/30) vesicles had an average 
size close to 140 nm.  
Interestingly, EcAMP1R2 only induces aggregation in IML vesicles. Aggregation of these 
LUVs is far of being concomitant with an electroneutralization of the vesicles (See Figure 
11). The first aggregating concentration observed was 5 µM (peptide-to-lipid ratio = 0.025). 
From this concentration on, the extent of aggregation seems to be dose-dependent, with an 
increase in sample polydispersity. This threshold concentration overlaps with the range of 
peptide concentrations at which surface charge stabilization occurs. 
When analyzing the lipid composition of the different vesicles used (Table 1), it seems that 
the higher content in cardiolipin is the differential trait of IML that could explain its AMP-
driven aggregation tendency. POPE and POPG, the other major components of IML vesicles 
are also present in the OML and POPC:POPG (70/30) vesicles, but none of these aggregate. 
Besides, although OML vesicles also have CL, the content of this lipid is very low (1%), and 
previous results suggest that EcAMP1R2 has an increased affinity towards LPS, thus 
competing with a low amount of CL molecules. We therefore hypothesize that the 
aggregation of IML vesicles might be due to an increased relative affinity of the peptide 
towards CL.  
CL is an anionic phospholipid, with a small head group relative to the volume occupied by its 
four acyl tails. Therefore, CL is often represented with a conic geometry and has a large 
intrinsic negative curvature76. Phospholipids with intrinsic negative curvatures — not only 
CL, but also POPE — can self assembly into monolayers that bend back towards the 
headgroups, i.e., with a concave shape of their hydrophilic surfaces64. This is the main reason 
why, in rod-shaped cells such as E. coli, CL concentrate at the membrane poles, forming finite 
domains64. Moreover, the intrinsic negative curvature of CL determine the influence of this 
phospholipid over the membrane environment, in terms of physical properties, increasing 
membrane fluidity and decreasing its packing70. In vesicles, it has been suggested that the 
morphologic features of CL can lead to local invaginations, and inter-bilayer contacts77. In the 
context of peptides and proteins, it has been extensively reported that positively charged 
amino-acid residues can interact with CL, reducing the electrostatic repulsion, thereby 
promoting the formation of CL domains26,75,78. The formation of such microdomains by 
means of the peptide has even lead to the proposal of an alternative model of AMP action, the 
so called peptide-induced lipid segregation model79. 
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Thus, for the issue of how EcAMP1R2 promotes IML vesicles aggregation without 
neutralizing their charge, we propose a hemi-fusion (or fusion) mechanism, due to a peptide-
driven clustering of CL molecules. First, polycationic molecules of EcAMP1R2 would gather 
CL molecules through electrostatic forces, forming CL microdomains. We hypothesize that 
the depolarization of IML vesicles at low peptide concentrations (see Figure 10) could be due 
to this selectivity of EcAMP1R2 to the CL headgroups. The "plateau phase", in which the 
surface potential remains unaltered, would correspond to a stabilization of the system. In this 
phase, the polar headgroups of POPG would be the main contributors to the surface charge.  
Thereafter, further interactions between EcAMP1R2 and IML vesicles would promote a 
curvature deformation in the CL domains. Distortions in membrane curvatures are often 
caused by membrane active peptides (AMPs, FPs, CPPs and cell penetrating peptides)13, 
especially in membranes rich in lipids with intrinsic negative curvature, such as POPE or CL 
(both present in IML vesicles)80. Finally, the warped outer leaflets of adjacent IML vesicles 
would form a concave stalk that would fuse or hemi-fuse (Figure 13), a mechanism first 
described by Chernomordik et al.81. This hypothesis is in good agreement with previous 
findings from our group49. In that work, it was shown, using AFM, that the leakage effect 
produced by rPBI21 (an AMP) on E. coli cells was polar-biased. In rod shaped bacteria, these 
polar regions are where CL preferentially locates, due to the conic shape of this phospholipid. 
 
 
Figure 13. Scheme of the proposed peptide-driven (hemi-)fusion mechanism of IML vesicles caused by 
EcAMP1R2. (A) Peptide-driven formation of CL (depicted as four-tailed phospholipids) microdomains. (B) 
Formation of concave phases and hemi-fusion. The position of the peptide in the lipid bilayer is merely 
illustrative.  
 
In principle, some changes in the fluidity and packing of the vesicles would be expected when 
fusion or hemi-fusion takes place. However, due to the fact that IML vesicles present low 
amounts of CL (4 %), the clustering effect of the peptide would translate into small isolated 
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domains prone to (hemi-)fusion. Therefore, the peptide would favor the formation of local 
dynamic hemi-fusion hotspots in vesicles, increasing their hydrodynamic diameter, but that 
presumably would not alter the zeta-potential of the vesicles.  
Altogether, our results in IML LUVs suggest an important role of the peptide-CL interaction 
in the destabilization of these vesicles. The confirmation of this hypothesis would imply 
important biological consequences. CL is an essential component of energy transducing 
membranes, serving as a proton trap for a subsequent proton translocation required for the 
ATP synthesis64. Besides, CL intimately interacts with many membrane proteins, including 
respiratory chain complexes and substrate carrier proteins82. Thus, given the essential role of 
CL domains in keeping the stability of energy transducing proteins, antimicrobial peptides 
might be exerting an indirect effect on the energy homeostasis of cells83.  
Besides, as the proportion of anionic lipids is relatively lower in Gram-negative bacteria than 
in Gram-positive bacteria, the increased affinity of EcAMP1R2 towards these lipids would 
mean a lower peptide-to-lipid ratio necessary for the peptide to segregate anionic lipids26. 
This could explain the lower MIC value of EcAMP1R2 in E. coli, in comparison to Gram-
positive bacteria.  
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Conclusions and perspectives 
Specific components of membranes (lipids, proteins, ions, etc.) can play a determinant role in 
the mode of action of AMPs. Although AMPs selectivity is sometimes seen as a merely 
electrostatic driven event, accumulating data27,28,51 indicate that things are not that simple. In 
this work, we have investigated the selectivity and activity of EcAMP1R2, a cationic AMP 
highly effective against E. coli cells. To do so, we tested lipid vesicles with increasing 
complexity, trying to elucidate the relative contribution of the diverse lipids to the peptide-
membrane interactions. Studies with E. coli cells have also been performed, trying to 
guarantee the biological relevance of this research. We conclude that, indeed, lipid 
composition plays an important role in the mode of action of EcAMP1R2. This AMP has a 
negligible affinity towards zwitterionic vesicles, as evidenced by the quenching assay and by 
the fact that the peptide addition does not alter any of the studied membrane physical 
properties. Conversely, EcAMP1R2 interacts with anionic membranes, and the extent of the 
interaction seems to be greater for the vesicles that mimic outer and inner membranes of E. 
coli cells. Zeta-potential and di-8-ANEPPS assays results aim to a similar behavior between 
E. coli cells and outer membrane mimicking vesicles, suggesting that activity is exerted at the 
outer membrane level. However, EcAMP1R2 seems to partition more into IML vesicles 
mimicking the inner membrane of E. coli, and increasing the lipid packing of these vesicles. 
However, the exact target of the peptide is still unclear and this question should be tackled. 
Besides, EcAMP1R2 promoted vesicle aggregation of IML. Interestingly, the aggregation is 
not concomitant with an expected vesicle electroneutralization, which led us to propose a 
fusion or hemi-fusion mechanism, dependent upon the clustering of CL molecules. Briefly, 
EcAMP1R2 would cause a lateral displacement of the CL molecules of the vesicle, creating 
microdomains. Thereafter, further interactions between the peptide and the CL microdomains 
would favor phase transition, which would result into a curvature distortion, prone to hemi-
fusion. However, this hypothesis must be further addressed in future experiments. All in all, 
the results of this work aim to that the rationally designed peptide EcAMP1R2 is a good 
candidate to fight Gram-negative bacteria, acting at the outer membrane level, but having also 
demonstrated activity in inner membrane models. An interesting possibility to explore is the 
ability of this peptide to act synergistically when combined with other antibiotic substances. 
From a therapeutic point of view, such synergistic interactions can mend some of the 
drawbacks associated to AMPs high costs, insufficient potency, and undesired cytotoxicity, 
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by allowing to reduce the dose necessary. The results of this work also highlight the 
importance of working with realistic model membranes, yielding valuable information that 
would be missed using the more simplistic models.  
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